Evidence map›Paper›PMID 28768961›Full record

ArticleInternal medicine (Tokyo, Japan)2017

The Rate of Referral of Hepatitis Virus Carriers to Hepatologists and the Factors Contributing to Referral.

Kazuhide Takata, Akira Anan, Daisuke Morihara, Kaoru Yotsumoto, Kunitoshi Sakurai, Atsushi Fukunaga, Takashi Tanaka, Keiji Yokoyama, Yasuaki Takeyama, Makoto Irie and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kazuhide TakataDepartment of Hepatology, Hakujyuji Hospital, Japan.
Akira AnanDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Daisuke MoriharaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Kaoru YotsumotoDepartment of Hepatology, Hakujyuji Hospital, Japan.
Kunitoshi SakuraiDepartment of Hepatology, Hakujyuji Hospital, Japan.
Atsushi FukunagaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Takashi TanakaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Keiji YokoyamaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Yasuaki TakeyamaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Makoto IrieDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Satoshi ShakadoDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Tetsuro SohdaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Shotaro SakisakaDepartment of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan.
Fukuoka University · JPUji Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The aims of the present study were to determine the proportions of hepatitis B surface antigen (HBsAg)-positive and anti-hepatitis C virus (HCV)-positive patients, and identify the characteristics that influenced referral to a hepatologist. Methods The present study included patients who were positive for HBsAg (n=153) or anti-HCV (n=574); their viral status was tested by non-hepatologists between January 2008 to December 2012. We performed a multivariate analysis to investigate the factors associated with the referral of patients to hepatologists. Results The rates of hepatitis B virus (HBV) and the percentage of suspected HCV carriers at the hospital were 1.4% and 3.5%, respectively. Among the 727 patients who were seropositive for HBV or HCV, 107 (14.7%) were referred to a hepatologist. A multivariate analysis to investigate the factors contributing to referral revealed that (i) an alanine aminotransferase (ALT) level of >30 IU/L [odds ratio (OR), 3.24; 95% confidence interval (CI), 2.10-5.03; p<0.001]; (ii) undergoing testing at an internal medicine department (OR, 2.79; 95% CI, 1.80-4.38; p<0.001); and (iii) HBsAg-positivity (OR, 2.22; 95% CI, 1.35-3.61; p=0.002) were factors that significantly influenced referral. Conclusion Hepatologists must educate non-hepatologists, especially non-internists, to promote the referral of hepatitis-virus carriers, especially HCV carriers, even in patients with ALT levels of <30 IU/L.

Indexed as

AdolescentAdultAgedAged, 80 and overAlanine TransaminaseCarrier StateFemaleGastroenterologistsHepatitis BHepatitis B Surface AntigensHepatitis B virusHepatitis CHumansMaleMiddle AgedReferral and ConsultationAlanine TransaminaseHepatitis B Surface AntigensHBVHCVhepatitis virus carriersmedical collaborationnon-hepatologist

Identifiers

PMID28768961
PMCPMC5577067
OpenAlexW2740246524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.